Bay Area Tumor Institute — Oakland, California

Public research footprint of Bay Area Tumor Institute, compiled from the ClinicalTrials.gov public registry.

327

Registered studies

Active

Recruiting now

223

Completed

Stopped or withdrawn

Most-studied conditions

Invasive Breast Carcinoma · Recurrent Ovarian Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Breast Cancer AJCC v6 and v7

Recently updated registry entries

NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT03866382 — Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One… (Recruiting)
NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Bay Area Tumor Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.